Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
SFL Corp
SFL
$1.64B
| $13.9M | 0.01% |
956,397
+169,965
| +22% | +$2.46M |
|
1227
Accuray
ARAY
$33.9M
| $13.9M | 0.01% |
4,926,313
+35,804
| +0.7% | +$99.4K |
|
|
HMLP
1228
DELISTED
HOEGH LNG PARTNERS LP
HMLP
| $13.9M | 0.01% |
888,099
+131,800
| +17% | +$2.04M |
|
1229
National Presto Industries
NPK
$871M
| $13.9M | 0.01% |
156,900
+17,300
| +12% | +$1.51M |
|
1230
Energy Transfer Partners
ET
$69.6B
| $13.9M | 0.01% |
1,080,145
+105,767
| +11% | +$1.3M |
|
1231
Martin Marietta Materials
MLM
$32.4B
| $13.8M | 0.01% |
+49,470
| New | +$13.2M |
|
1232
Mizuho Financial
MFG
$126B
| $13.8M | 0.01% |
4,466,385
+208,785
| +5% | +$650K |
|
|
WUBA
1233
DELISTED
58.com Inc
WUBA
| $13.8M | 0.01% |
212,863
+54,000
| +34% | +$3.04M |
|
1234
Performance Food Group
PFGC
$18B
| $13.8M | 0.01% |
267,400
+147,100
| +122% | +$6.72M |
|
1235
Digi International
DGII
$2.57B
| $13.8M | 0.01% |
776,284
+3,400
| +0.4% | +$54K |
|
1236
Invesco Senior Loan ETF
BKLN
$6.97B
| $13.7M | 0.01% |
601,900
+568,554
| +1,705% | +$12.8M |
|
1237
Commercial Vehicle Group
CVGI
$147M
| $13.7M | 0.01% |
2,161,007
+23,207
| +1% | +$165K |
|
|
BOLD
1238
DELISTED
Audentes Therapeutics, Inc
BOLD
| $13.7M | 0.01% |
228,100
+149,400
| +190% | +$5.61M |
|
|
SHI
1239
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $13.6M | 0.01% |
446,648
+58,240
| +15% | +$1.66M |
|
|
VRTU
1240
DELISTED
Virtusa Corporation
VRTU
| $13.6M | 0.01% |
300,596
-29,500
| -9% | -$1.2M |
|
1241
Oppenheimer Holdings
OPY
$1.19B
| $13.6M | 0.01% |
495,300
+26,200
| +6% | +$730K |
|
1242
Heartland Express
HTLD
$986M
| $13.6M | 0.01% |
646,533
-71,700
| -10% | -$1.54M |
|
|
GLOG
1243
DELISTED
GASLOG LTD
GLOG
| $13.6M | 0.01% |
1,389,599
-6,401
| -0.5% | -$72.8K |
|
|
PCTI
1244
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $13.6M | 0.01% |
1,606,037
+39,304
| +3% | +$326K |
|
1245
iShares National Muni Bond ETF
MUB
$45.2B
| $13.6M | 0.01% |
119,100
+80,919
| +212% | +$9.22M |
|
|
NATI
1246
DELISTED
National Instruments Corp
NATI
| $13.6M | 0.01% |
+320,266
| New | +$13.4M |
|
1247
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $13.6M | 0.01% |
154,100
+69,500
| +82% | +$6.05M |
|
|
CHA
1248
DELISTED
China Telecom Corporation, LTD
CHA
| $13.5M | 0.01% |
328,900
+41,700
| +15% | +$1.75M |
|
1249
Mercer International
MERC
$39.5M
| $13.5M | 0.01% |
1,098,300
-172,841
| -14% | -$2.11M |
|
1250
Carlisle Companies
CSL
$15B
| $13.5M | 0.01% |
83,300
-159,400
| -66% | -$24.6M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.